Sign up to save your podcasts
Or
Share AAD 2019 meeting wrap-up
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AAD 2019 meeting wrap-up
Today, we’re bringing you a special episode featuring exclusive coverage from the annual meeting of the American Academy of Dermatology in Washington.
In a wide-ranging discussion, Dr. Julie Harper and Dr. Jonette Keri sum up their key insights and take-home messages from the meeting’s acne sessions.
We also bring you the latest in dermatology news and research from the meeting:
1. Food allergies and atopic dermatitis: What is the evidence? https://bit.ly/2CayGcp
2. Many common dermatologic drugs can be safely used during pregnancy. https://bit.ly/2HmZLfY
3. 31-GEP test predicts likelihood of metastasis for cutaneous melanoma. https://bit.ly/2NO3dkK
4. Bermekimab reduces lesions, cuts pain in patients with hidradenitis suppurativa. https://bit.ly/2H6NuNe
Contact us: [email protected]
On Twitter: @MDedgeDerm
View all episodes
By Medscape Professional Network
4.3
3636 ratings
Today, we’re bringing you a special episode featuring exclusive coverage from the annual meeting of the American Academy of Dermatology in Washington.
In a wide-ranging discussion, Dr. Julie Harper and Dr. Jonette Keri sum up their key insights and take-home messages from the meeting’s acne sessions.
We also bring you the latest in dermatology news and research from the meeting:
1. Food allergies and atopic dermatitis: What is the evidence? https://bit.ly/2CayGcp
2. Many common dermatologic drugs can be safely used during pregnancy. https://bit.ly/2HmZLfY
3. 31-GEP test predicts likelihood of metastasis for cutaneous melanoma. https://bit.ly/2NO3dkK
4. Bermekimab reduces lesions, cuts pain in patients with hidradenitis suppurativa. https://bit.ly/2H6NuNe
Contact us: [email protected]
On Twitter: @MDedgeDerm